Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. (Q48226355)

9 February 2018

title

Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. (English)

1 reference

9 February 2018

1 reference

2

1 reference

9 February 2018

author name string

To CT

series ordinal

1

1 reference

9 February 2018

publication date

1 February 1999

1 reference

9 February 2018

published in

Neuropharmacology

1 reference

9 February 2018

volume

38

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

279-282

1 reference

9 February 2018

Comparison of relative potencies of i.v. and i.c.v. administered 8-OH-DPAT gives evidence of different sites of action for hypothermia, lower lip retraction and tail flicks.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Can social interaction be used to measure anxiety?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Pharmacological characterisation of a modified social interaction model of anxiety in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Neuropharmacology of anxiety: perspectives and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

CCK in animal and human research on anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Cholecystokinin activates area postrema neurons in rat brain slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900176-2

10.1016/S0028-3908(98)00176-2

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

release_ngta3ndeqjaklmojnqfkoqncoa

Fatcat ID

0 references

PubMed ID

10218869

1 reference

9 February 2018